Week 3 Flashcards

1
Q

What are the different types of drug receptors

A

Enzymes:
-cyclooxygenase; the aspirin receptor
Ion channels:
-Ca2+ channels blocked by nifedipine used to manage hypertension, angina, raynauds phenomenon
Transporters (pumps, transport proteins):
-noradrenaline transporter blocked by cocaine
‘Physiological’ receptors- receptors for hormones, neurotransmitters etc :
-acetylcholine, histamine, insulin etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nomenclature around drugs

A

In pharmacology distinct words used for drugs depending on the effect they have on a certain receptor
E.g. -100% efficacy= full inverse agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ways of regulating cell function

A

Altered membrane potential
Altered enzyme activity
Altered gene expression
Most drugs affect cell function via physiological receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is agonism

A

How drugs produce effects by binding to receptors- various ways in which effects are produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is antagonism and desensitization

A

How drugs block effects by binding to receptors- ways in which effects blocked or reduced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why are partial agonists worse

A

Reduced frequency of open channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a partial agonist

A

An agonist which is unable to induce maximal activation of a receptor population regardless of amount of drug applied
Lower efficacy than a full agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a inverse agonist

A

Is a ligand that binds to the same receptor-binding site as an agonist and not only antagonises the effects of an agonist but also exerts the opposite effect by suppressing spontaneous receptor signalling
Have negative efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is meant by allosteric effects on receptors

A

The allosteric modulation may result in slowing or inhibition of binding of ligands to the orthosteric binding site causing weakening of a signal or decreased activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Super-agonists

A

Highly efficacious agonists
Can produce a maximal response from the cell without binding to all of the available receptors
Emax for these then >100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Example of super-agonist

A

Goserelin (Zoladex) is a super agonist of the gonadotropin-releasing hormone receptor (GnRH-R).
It suppresses production of the sex hormones (testosterone and oestrogen) particularly in the treatment of breast and prostrate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Example of partial agonist

A

Buprenorphine is an opioid used to treat opioid addiction, moderate acute pain and moderate chronic pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are competitive antagonists

A

Bind reversibly at the same site as the (natural) agonist doesn’t activate it, blocks action
Produce a parallel shift to the right of agonist dose/response curves
Need a higher concentration of agonists to get same effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are irreversible antagonists

A

Bind irreversibly at the same site as the agonist, forming a covalent bond or binding incredibly tight
Decrease maximal response to agonists
May produce an initial shift to the right of the dose/response curve with no decrease in max
Evidence for spare receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are allosteric antagonists

A

Rare
Bind reversibly at a distinct site from agonist and decrease agonist affinity
Reduce likelihood of agonist binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are channel blockers

A

Bind inside the channel and prevent passage of ions
Binding of channel blockers tends to be enhanced by receptor activation
Use dependence

17
Q

What are physiological antagonists

A

They antagonise the physiological effect of some agonists but via different mechanism. Opposite effect of agonist, will indirectly oppose action of agonist
Several substances that have anti-histaminergic action despite not being ligands for the histamine receptor are physiological antagonists to histamine

18
Q

What are the classes of antagonists

A

Competitive antagonists
Irreversible antagonists
Allosteric antagonists
Channel blockers
“Physiological antagonists”

19
Q

How are receptors classified

A

On the basis of the selective action of drugs
They’re named according to the transmitter or hormone with which they interact

20
Q

What are the receptor super families

A

Integral ion channels e.g. Nicotinic receptor glycine receptor
Integral tyrosine kinases e.g. insulin receptor
Steroid receptors =nuclear receptors e.g. oestrogen receptor, androgen receptor
G protein coupled receptors e.g. muscarinic receptors, adrenoreceptors
Cytokine receptors e.g. prolactin receptor

21
Q

Nuclear receptors

A

Act in the nucleus but most often located in the cytoplasm
Their ligand binding domain functions like a folding sensor. Without steroid ligand its unfolded and with steroid its folded
The DNA binding domain mediates binding of nuclear receptors to thousands of sites within genome

22
Q

What can be a drug receptor

A

Anything that a drug binds to, to produce its pharmalogical effect

23
Q

How does asparaginase act

A

As a medication, L-asparaginase is used to treat acute lymphoblastic leukaemia, acute myeloid leukaemia, and non-Hodgkin’s lymphoma. It’s given by injection into a vein, muscle or under skin

24
Q

What is toxicology

A

The study of the unwanted or deleterious effects of drugs or chemicals on the body

25
Q

What does the distribution of drugs into CNS usually depend on

A

Lipid diffusion

26
Q

What can competition between two drugs for binding to plasma proteins result in

A

Change in concentration of free drug and potential drug toxicity

27
Q

When considering absorption of drugs weakly basic drugs have a higher solubility at

A

Lower pH

28
Q

At which stage of drug development can it first be proved that a drug is effective

A

Phase II trials